Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

PDL BioPharma

Summary

On January 9, 2006, Protein Design Labs and its wholly-owned subsidiary ESP Pharma became known as PDL BioPharma. The transition to a new name coincides with the integration of the company's former subsidiary, ESP Pharma into Protein Design Labs, creating a single organization and operating structure, now known as PDL BioPharma. PDL BioPharma has chosen this new name to better reflect its status as a commercial biopharmaceutical company focused on discovering, developing and marketing innovative therapies for serious or life-threatening illnesses.

R&D

To view this information, you must subscribe to Partneringtools.

Partnerships

To view this information, you must subscribe to Partneringtools.

Deals

To view this information, you must subscribe to Partneringtools.

Senior management

To view this information, you must subscribe to Partneringtools.

Board of directors

To view this information, you must subscribe to Partneringtools.
Partnering consultation free of charge
Therapeutic Area Partnerships
Bioiberica
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us